|
rdf:type |
|
|
lifeskim:mentions |
umls-concept:C0003280,
umls-concept:C0004238,
umls-concept:C0040223,
umls-concept:C0087111,
umls-concept:C0205099,
umls-concept:C0302350,
umls-concept:C0332306,
umls-concept:C0442027,
umls-concept:C0444706,
umls-concept:C0454664,
umls-concept:C0525032,
umls-concept:C0814225,
umls-concept:C1514721,
umls-concept:C2587213
|
|
pubmed:issue |
20
|
|
pubmed:dateCreated |
2008-11-12
|
|
pubmed:abstractText |
Oral anticoagulation (OAC) therapy is effective in atrial fibrillation but requires vigilance to maintain the international normalized ratio in the therapeutic range. This report examines how differences in time in therapeutic range (TTR) between centers and between countries affect the outcomes of OAC therapy.
|
|
pubmed:language |
eng
|
|
pubmed:journal |
|
|
pubmed:citationSubset |
AIM
|
|
pubmed:chemical |
|
|
pubmed:status |
MEDLINE
|
|
pubmed:month |
Nov
|
|
pubmed:issn |
1524-4539
|
|
pubmed:author |
|
|
pubmed:issnType |
Electronic
|
|
pubmed:day |
11
|
|
pubmed:volume |
118
|
|
pubmed:owner |
NLM
|
|
pubmed:authorsComplete |
Y
|
|
pubmed:pagination |
2029-37
|
|
pubmed:meshHeading |
pubmed-meshheading:18955670-Administration, Oral,
pubmed-meshheading:18955670-Aged,
pubmed-meshheading:18955670-Aged, 80 and over,
pubmed-meshheading:18955670-Anticoagulants,
pubmed-meshheading:18955670-Aspirin,
pubmed-meshheading:18955670-Atrial Fibrillation,
pubmed-meshheading:18955670-Brazil,
pubmed-meshheading:18955670-Drug Therapy, Combination,
pubmed-meshheading:18955670-Europe,
pubmed-meshheading:18955670-Humans,
pubmed-meshheading:18955670-International Normalized Ratio,
pubmed-meshheading:18955670-Middle Aged,
pubmed-meshheading:18955670-North America,
pubmed-meshheading:18955670-Platelet Aggregation Inhibitors,
pubmed-meshheading:18955670-Quality Control,
pubmed-meshheading:18955670-South Africa,
pubmed-meshheading:18955670-Ticlopidine,
pubmed-meshheading:18955670-Time Factors,
pubmed-meshheading:18955670-Treatment Outcome
|
|
pubmed:year |
2008
|
|
pubmed:articleTitle |
Benefit of oral anticoagulant over antiplatelet therapy in atrial fibrillation depends on the quality of international normalized ratio control achieved by centers and countries as measured by time in therapeutic range.
|
|
pubmed:affiliation |
Population Health Research Institute, McMaster University, Hamilton, Ontario, Canada. connostu@phri.ca
|
|
pubmed:publicationType |
Journal Article,
Randomized Controlled Trial,
Research Support, Non-U.S. Gov't,
Multicenter Study
|
